Results and Exploratory Biomarker Analyses of a Phase II Study CHANGEABLE: Combination of HX008 and Niraparib in Germ-Line-mutated Metastatic Breast Cancer.
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2024)